Joseph K. Belanoff, Chief Executive Officer at CORCEPT THERAPEUTICS INC (CORT), sold 80,000 shares at $69.65 ($5.5M) on 2025-08-01, disclosed to the SEC on 2025-08-05.
Scheduled sale ($5.5M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $67.81 | 16,745 | $1.1M | 20.7% |
| 2 | $67.81 | 16,745 | $1.1M | 20.7% |
| 3 | $68.87 | 17,809 | $1.2M | 22.4% |
| 4 | $68.87 | 17,809 | $1.2M | 22.4% |
| 5 | $69.65 | 5,446 | $379K | 6.9% |
| 6 | $69.65 | 5,446 |
| $379K |
| 6.9% |
| Total | $68.53 avg | 80,000 | $5.5M | 100% |
| Filing → |
| CORT | SELL | 2026-03-27 | $2.6M | — | Filing → |
| CORT | SELL | 2025-12-03 | $3.2M | — | Filing → |
| CORT | SELL | 2025-11-05 | $4.9M | — | Filing → |